Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 25, 2015 2:17 PM ET

Healthcare Providers and Services

Company Overview of AmerisourceBergen Drug Corporation

Company Overview

AmerisourceBergen Drug Corporation provides pharmaceutical distribution and pharmacy management solutions to reduce costs, increase efficiency, and improve patient care for retail pharmacy, alternate care pharmacy, and hospital pharmacy markets. It offers distribution, pharmacy automation, professional, specialty distribution, customer, and off-site packaging services; and quality care, cost control, market growth, pharmacy consulting, and technology solutions. The company serves pharmaceutical manufacturers, consumer product manufacturers, non-healthcare goods and service providers, independent pharmacies, and chain pharmacies. AmerisourceBergen Drug Corporation was incorporated in 1985 and...

1300 Morris Drive

Suite 100

Chesterbrook, PA 19087

United States

Founded in 1985

Phone:

610-727-7000

Fax:

610-647-0141

Key Executives for AmerisourceBergen Drug Corporation

Senior Vice President of Sales and Marketing
Compensation as of Fiscal Year 2014.

AmerisourceBergen Drug Corporation Key Developments

AmerisourceBergen Drug Corporation Promotes Robert P. Mauch to President

AmerisourceBergen Corporation announced that Robert P. Mauch, 48, PharmD, PhD, has been promoted to Executive Vice President and President of AmerisourceBergen Drug Corporation, effective immediately. Previously, Mauch served as AmerisourceBergen Drug Corporationâ s Senior Vice President and Chief Operating Officer. David W. Neu will transition from his previous role as President of AmerisourceBergen Drug Corporation to assume the newly created position of Executive Vice President of Retail Strategy and President of Good Neighbor Pharmacy.

PharMerica Corporation Provides Legal Update in its Lawsuit with AmerisourceBergen Drug Corporation

PharMerica Corporation commenced litigation against AmerisourceBergen Drug Corporation in the Jefferson County Circuit Court of Kentucky on September 10, 2014. After the Lawsuit was filed in Kentucky, Amerisource commenced litigation against the Corporation in the Court of Chancery in the State of Delaware in an attempt to have the case heard in Delaware rather than Kentucky. On November 10, 2014, the Delaware Court of Chancery ruled that it did not have subject matter jurisdiction over the matter because Amerisource had filed the litigation in the incorrect court in Delaware. In so ruling, the Court of Chancery noted its belief that the case should be heard in Kentucky and not Delaware, while noting that the Delaware Superior Court would ultimately decide that issue. On November 20, 2014, the parties to the Delaware action stipulated to its voluntary dismissal. Following the commencement of the Lawsuit, Amerisource unilaterally instituted several changes to its obligations under the Amended and Restated Prime Vendor Agreement, as amended between the Corporation and Amerisource, which the Corporation believed were made in retaliation against the corporation for commencing the Lawsuit and seeking to enforce its rights under its Prime Vendor Agreement. On October 8, 2014, the Corporation filed a Motion for a Temporary Injunction against Amerisource to prohibit Amerisource from imposing automatic drug substitution programs on its transactions with the Corporation. The court heard the Motion for Temporary Injunction on November 13, 2014. On November 24, 2014, the court issued a temporary injunction against Amerisource. The temporary injunction will remain in effect for the duration of the litigation between the Corporation and Amerisource. Amerisource will have 20 days to appeal the injunction to the Kentucky Court of Appeals. The Corporation is pursuing claims for monetary damages that resulted from the actions of Amerisource upon which the injunction was based. At this time, the Corporation is unable to determine the ultimate impact of these litigation proceedings on its consolidated financial condition, results of operations, or liquidity. The litigation proceedings with Amerisource could continue for an extended period of time, likely longer than 18 months. Although the Corporation is confident in the merits of its case, until the resolution or settlement of such proceedings, the Corporation cannot provide any assurances about the collectability of the disputed amounts owed by Amerisource.

AmerisourceBergen Drug Corp. Wins $4.06 Billion Federal Contract

AmerisourceBergen Drug Corp. was awarded a federal contract valued at up to $4,055,350,448 by the Defense Logistics Agency Troop Support, Philadelphia, for prime vendor pharmaceutical and pharmaceutical-related products and support for worldwide distribution.

Similar Private Companies By Industry

Company Name Region
Wellness Inc. United States
Daughters Of Charity Services Of San Antonio Inc. United States
Palm Drive Hospital L.P. United States
PresenceLearning, Inc. United States
Cascadia Behavioral Healthcare, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Bankruptcy
April 29, 2014
Vestiq Holdings, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AmerisourceBergen Drug Corporation, please visit www.amerisourcebergendrug.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.